With both every 1 mmol/L increase and every 1 SD increase in FG, there were also heightened risks of developing gestational hypertension, pre-eclampsia, maternal insulin use, primary Caesarean section, shoulder dystocia, macrosomia, LGA, neonatal hypoglycaemia and NICU admission, but the risk of developing SGA was lowered. The gene discussed is INS; the disease is preeclampsia.